Press releases and general news items involving Plakous Therapeutics Inc.
Plakous Therapeutics, Inc. has been granted orphan drug and rare pediatric disease designations for its human placental extract, Protego-PDTM for the prevention of necrotizing…Read More
Mayo Clinic Agreement
Plakous Therapeutics, Inc. announced that it has signed a know-how license agreement with Mayo Clinic. The multi-year agreement will focus on understanding the results of a na…Read More
NIH Funding Award
Plakous Therapeutics, Inc. received a notice of award for a Phase I-II Fast-Track Small Business Innovation Research (SBIR) grant providing up to $1,725,000 from the Eunice…Read More
Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina Biotechnology Center (NCBiotech)…Read More